Heart failure market set to grow strongly, says GlobalData

Analysts project the heart failure market to grow at a compound rate of 9.6% over the next decade, increasing from $13.5 billion in 2022 to $33.7 billion in 2032 across seven major markets.

Key factors behind this growth include the approval of new therapies with diverse mechanisms of action and an expanding population of newly diagnosed patients.

The report highlights the USA as the largest contributor, driven by a higher prevalence of heart failure and significantly higher prescription drug costs compared with Europe and Japan.